搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Businessworld
4 小时
Yolo 247 referral code 2024
Yolo 247 referral code 2024 With all employees receiving salary cuts and more than half of the staff being laid off, is it really true that ...
Swissinfo
1 天
More people switching to generic medicine in Switzerland
Measures to encourage more people in Switzerland to use generic medicine in place of brand name originals appear to be working.
AOL
1 天
What is Compounded Tirzepatide? Here's What You Need to Know
Tirzepatide is the active ingredient in the FDA-approved versions of the drug, Mounjaro and Zepbound ... These are the same ...
3 天
Indies Pharma looks to earn from FDA-approved drug next year
Following the recent approval of its Regadenoson generic drug by the United States Food and Drug Administration (FDA), Indies ...
4 天
FDA approves GLP-1 generic for Type 2 diabetes
The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...
4 天
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see ...
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
4 天
Competition will make weight-loss drugs better, cheaper and bigger
Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...
KHQ
4 天
FDA approves generic diabetes treatment option
UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...
4 天
on MSN
Daily Briefing: I'll be home for Christmas (if the weather allows)
I'm Nicole Fallert, Daily Briefing author. This newsletter will be taking a pause for cookies and listening to "Last ...
4 天
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of ...
Duquesne Family Office's chief is cashing in his chips on two leading artificial intelligence (AI) stocks in favor of a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈